GSK3B and Alzheimer disease: Therefore, we aim to investigate new treatments derived from fungal metabolites using molecular docking and ADMET methods, as well as to examine their therapeutic multitarget potential against three important AD target proteins (GSK-3β, NMDA receptor, and BACE-1).